Diabetes research hub

Diabetes Interventional Assessment of Slimming or Training to Lessen Inconspicuous Cardiovascular Dysfunction

This study looks at how type 2 diabetes affects the heart in younger adults. We're testing if a special diet plan or an exercise programme can improve heart health and reverse fatty changes in the liver and heart, compared to standard care.

The Man Van Project

The Man Van project offers mobile health checks at workplaces and communities for men, especially those from ethnic minority groups, to find health problems like prostate cancer early. The goal is to make healthcare easier to access and improve men's health outcomes.

Enhanced DPP-GLB to Promote Weight Loss Among Nonresponders in a Community-Based Lifestyle Intervention.

This study looks at how to help people who are finding it hard to lose weight in a community-based program. It focuses on those at risk of diabetes, especially Black adults, offering extra support and resources to see if it helps them lose weight and stay healthier.

User Evaluation of a Home-collection Kit for People With Diabetes

This study is testing a new home blood test kit for people with diabetes. It aims to make it easier for you to check your diabetes control (HbA1c) from home, so you don't always need to visit a clinic. We want to see if these home kits work well and are helpful.

Low Energy Diet and Familial Partial Lipodystrophy

This study looks at how a special low-calorie diet can help people with a rare condition called familial partial lipodystrophy and type 2 diabetes. Participants will follow the diet for 12 weeks, aiming to improve their health and understand why the diet works.

Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study

This study uses smartwatches to understand how movement affects health for people with conditions like heart disease or diabetes. Researchers hope to find ways to predict health changes and improve wellbeing programmes using the information from the watches.

Semaglutide 2.4 mg in Patients With Poor Weight-loss

This study is looking at whether a medicine called semaglutide, given as a 3mg injection, can help people who haven't lost enough weight after weight-loss surgery. It compares semaglutide to a dummy treatment over 68 weeks to see if it helps with weight loss and overall health.

Personalized Responses to Dietary Composition Trial 3

This study, PREDICT 3, aims to understand how different foods affect individuals. By looking at how people respond to meals in their everyday life, it helps create more personalised eating advice to improve health for conditions like diabetes and heart problems.

Unrecognised Comorbidity Detection in Hospitalised Patients

This study aims to find hidden long-term conditions like diabetes and heart problems in hospital patients. By using routine hospital information, researchers hope to build a digital tool to identify patients who might benefit from earlier diagnosis and treatment, improving their health outcomes.

Assessing Remote Confirmation of Type 1 Diabetes

This study looks at sending home finger-prick kits to people treated for Type 1 diabetes to check how much insulin their body makes. This helps see if a simple home test can accurately check for Type 1 diabetes, potentially helping some avoid unnecessary insulin.

Cardiometabolic Health in First Time Pregnancy

This study looks at how pregnancy complications like high blood pressure can affect a woman's heart health and risk of diabetes later on. It aims to understand these links better and find ways to prevent future problems.

Randomised, crossover bioequivalence clinical trial of linagliptin 5 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions.

An open label, balanced, randomized, single dose, two treatment, two period, two sequence, crossover, bioequivalence study comparing Dapagliflozin tablets 10mg, manufactured by Sun Pharmaceutical Industries Limited, India with Forxiga (Dapagliflozin) film-coated tablets 10 mg, manufactured by AstraZeneca AB Gärtunavägen, SE-151 85 Södertälje Sweden, in healthy adult, human subjects under fasting condition

Randomised, crossover bioequivalence clinical trial of linagliptin/metformin 2.5 mg/1000 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fed conditions.

Bioequivalence clinical trial of dapagliflozin 10 mg tablets, after a single oral dose administration to healthy volunteers under fasting conditions.

An open label, balanced, randomized, single dose, two treatment, two period, two sequence, crossover, bioequivalence study comparing Empagliflozin Tablets 25 mg, manufactured by Sun Pharmaceutical Industries Limited, India with Jardiance (Empagliflozin) 25 mg film-coated tablets, Marketing Authorisation Holder Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein Germany, in healthy adult, human subjects under fasting condition.

Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bone fractures caused by acute Charcot foot in patients with diabetes mellitus (CHARCOT study)